November 13, 2026 · Gastroenterology · DOI: 10.1053/j.gastro.2026.10.383

Depletion of Endogenous IL-18 Suppresses Pancreatic Cancer Progression, Reprograms the Tumor Microenvironment, and Enhances KRAS Inhibitor Efficacy.

Listen to this summary

Pancreatic cancer is highly inflammatory and immunosuppressive, and IL-18 is elevated in this disease and linked to poor survival, but its functional role was unclear. Using genetically engineered mice with spontaneous PDAC, the authors show that depleting IL-18 slows tumor progression and prolongs survival, and that IL-18 promotes cancer cell survival by inducing STAT1-dependent CD47 expression that blocks macrophage phagocytosis. IL-18 loss also reprograms macrophages toward an antigen-presenting, phagocytic state and enhances clearance of KRAS inhibitor-treated cells, suggesting that targeting IL-18 could improve KRAS inhibitor therapy.

Xinlei Sun, Yifan Ma, Lingzhi Wang, Jian Gao, Yue Fei, Xiaowei Zhang, Rance B Tino, Yeseul Kim, Hua Wang, Kangyu Lin, Dongwei Zhang, Zhongming Zhao, Chunru Lin, John Paul Shen, Sue-Hwa Lin, Linghua Wang, Vincent Bernard, Eugene J Koay, Dan Zhao, Huamin Wang, Wen Jiang, Betty Y S Kim, Anirban Maitra, Yang Chen

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play